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Abstract
Background: Stent implantation into the tracheo-bronchial system may be life-saving in selected pediatric patients
with otherwise intractable stenosis of the upper airways. Following implantation, significant tissue proliferation may
occur, requiring re-interventions. We sought to evaluate the effect of immunosuppressive coating of the stents on
the extent of tissue proliferation in an animal model.
Methods: Bare metal and sirolimus-coated stents (Bx Sonic and Cypher Select, Johnson & Johnson, Cordis) were
implanted into non-stenotic lower airways of New Zealand white rabbits (weight 3.1 to 4.8 kg). Three stents with
sirolimus coating and six bare metal stents could be analyzed by means of histology and immunohistochemistry
12 months after implantation.
Results: On a macroscopic evaluation, all stents were partially covered with a considerable amount of whitish
tissue. Histologically, these proliferations contained fiber-rich connective tissue and some fibromuscular cells
without significant differences between both stent types. The superficial tissue layer was formed by typical
respiratory epithelium and polygonal cells. Abundant lymphocyte infiltrations and moderate granulocyte infiltrations
were found in both groups correspondingly, whereas foreign-body reaction was more pronounced around
sirolimus-eluting stents.
Conclusions: After stent implantation in the tracheo-bronchial system of rabbits, we found tissue reactions
comparable to those seen after stent implantation into the vascular system. There was no difference between
coated and uncoated stents with regard to quality and quantity of tissue proliferation. We found, however, a
significantly different inflammatory reaction with a more pronounced foreign-body reaction in sirolimus-coated
stents. In our small series, drug-eluting stents did not exhibit any benefit over bare metal stents in an experimental
setting.
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Background
Stenosis of the tracheo-bronchial system in children may
be life-threatening. Reasons include obstructing internal
structures (e.g., granulations or tumor), external com-
pression (e.g., lymph nodes or atypical vascular struc-
tures), or functional-dynamic changes of the airway wall
resulting in tracheomalacia [1, 2]. Preservation of patency
of the airways is the aim of any therapeutic intervention [3].
Functional improvement may be achieved by non-invasive
ventilation using continuous positive airway pressure which
is not tolerated by all patients. It may sometimes not even
be sufficient to guarantee adequate ventilation. Accordingly,
facing limited alternative therapeutic options, stent implant-
ation into the tracheo-bronchial system may be inevitable
and life-saving in otherwise intractable patients [4].
In the beginning, airway stents were made of silicone
for relief of subglottic stenosis [5]. Due to the closed de-
sign, these stents showed a high rate of migration and
could not be adapted to increased size of the airway
lumen in a growing individual. These limitations could
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in part be overcome with the introduction of bare metal
stents [6, 7]. In clinical practice, implantation of these
stents is an established therapeutic option with proven
efficacy and safety [8–10]. The main problem after bare
metal airway stents is the formation of obstructing
granulation tissue adjacent to the implant [4, 11].
The aim of our study was to evaluate the extent of tissue
proliferations after implantation of drug-eluting stents
with an anti-proliferative coating. To the best of our
knowledge, we report on the use of drug-eluting stents in
the trachea-bronchial system in an experimental setting
with the longest follow-up period (i.e., 12 months).
Methods
A total of 28 stents were implanted in the trachea-
bronchial system of New Zealand white rabbits (weight 3.1
to 4.8 kg at the time of implantation). Fourteen stents were
bare metal coronary stents (Bx Sonic, Johnson & Johnson,
Cordis, USA), and 14 had an anti-proliferative coating with
sirolimus (Cypher Select, Johnson & Johnson, Cordis,
USA), respectively. Re-evaluation and re-dilation (if neces-
sary) of the stents was performed after 1, 3, and 6 months.
Finally, the animals were sacrificed after 12 months.
For histopathologic evaluation, tissue blocks containing
the implant were dissected with a minimum of surround-
ing tissue immediately after explantation. After brief flush-
ing with saline, specimens were fixed in formalin (buffered
4 %). Prior to embedding, macroscopic evaluation and
photo documentation were accomplished. After fixation,
tissue blocks containing the devices were embedded in
resin methylmethacrylate (Technovit 9100, Kulzer & Co,
Wehrheim, Germany). Following hardening, resin blocks
were subsequently sectioned in slices of 0.8 mm using a
diamond band saw (300 CP, Exakt GmbH, Norderstedt,
Germany). These slices were ground down to 5–30 μm
with a horizontal rotatory grinder and polisher (400 CS,
Exakt GmbH, Norderstedt, Germany) [12].
Richardson blue was used as a standard histological
staining. In order to obtain immunostaining of resin em-
bedded specimen, sections were mounted on glass slides
using silicon glue, and deplastification was performed as
described previously by our group [13]. Counterstaining
of immunohistochemical stains was accomplished with
hemalaun. Negative controls were processed without the
antigen-specific antibody.
For semi-quantitative grading of histological findings,
a 3-grade scoring system was adopted from Schwartz
et al. for the following aspects: (a) extent of tissue pro-
liferation within the stent lumen and (b) inflammatory
reactions [14].
Results
A first series of 18 stents (9 Bx Sonic and 9 Cypher
Select) was implanted without complications. At the first
follow-up study 1 month after implantation, 13/18 stents
had been expectorated by the animals (6 Bx Sonic and 7
Cypher Select). The remaining five stents of this group
were lost until the next follow-up at 6 months.
A second series of implantations was initiated. An-
other ten stents were implanted (6 Bx Sonic and 4 Cy-
pher Select). The implantation procedure was modified
by implanting the stents with a larger diameter of the
balloon in relation to the airway diameter at the site of
implantation as documented by preceding bronchogra-
phy. Only one further stent (Cypher Select) was expecto-
rated until the first follow-up at 1 month. No further
stents were lost during the follow-up at 6 and 12 months.
Thus, nine stents were available for tissue analysis at the
end of the study 12 months after implantation (6 Bx
Sonic and 3 Cypher Select). Each of the stents had re-
quired re-dilation once during follow-up (Table 1).
Macroscopic evaluation
On gross examination, mild to moderate proliferation of
whitish material with a smooth glossy surface was seen
within the lumen of all stents. There were no signs of
local hemorrhage or stent fractures.
Granulation tissue
Histologically, significant proliferation of tissue was found
in all specimen around the stent struts (Fig. 1a–d). The
proliferations consisted of spindle-shaped cells with the
typical morphologic appearance of fibromuscular cells
surrounded by fiber-rich connective tissue (Fig. 2a). On
immunostaining, fibromuscular cells showed the typical
staining pattern with antibodies against smooth muscle
myosin (Fig. 2b), smooth muscle actin (Fig. 2c), and
Vimentin, a marker for cells of mesenchymal origin
(Fig. 2d). There was no difference in quantity or quality of
granulation tissue between the two groups of uncoated vs.
sirolimus-coated stents (Table 1).
Epithelialization
On the luminal surface of the newly formed tissue prolif-
erations, respiratory epithelium with the typical pattern of
aligned high-prismatic cells with cilia or polygonal cells
without cilia had formed (Fig. 2e). In some of the speci-
mens, cartilage structures had developed within the prolif-
erations (Fig. 2f).
Inflammatory reactions
Dense infiltrations of inflammatory cells were found in
all specimens (Table 1). Granulocytes were located pre-
dominantly around the stent struts (Fig. 3a), infiltrating
the respiratory epithelium (Fig. 2e). Lymphocyte infiltra-
tions showed an irregular distribution pattern through
all layers of the airway wall (Fig. 3b). Histiocytes (macro-
phages) were present in all specimens as well (Fig. 3c),
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but with a significant accumulation locally related to
stent struts of sirolimus-eluting stents. Formation of
multiple foreign-body giant cells was also found more
pronounced in these stents correspondingly (Fig. 3d).
Discussion
After stent implantation into the tracheo-bronchial system,
formation of granulation tissue with subsequent restenosis
is considered the most clinically relevant complication
beside stent dislocation [8–10, 15]. It is well-described that
inflammatory processes lead to the formation of these tis-
sue proliferations [16, 17].
The main focus of the present study is the reduction
of the degree of granulation tissue formation by employing
stents with anti-inflammatory coating. This concept was
adopted from the field of cardiology. In 2002, a large ran-
domized, double-blind study of bare metal vs. sirolimus-
eluting stents in patients with coronary artery disease had
shown a significant reduction of late lumen loss in the
coated stent group [18]. These results lead to the specula-
tion of improved efficacy of anti-inflammatory coating in
stents implanted into the tracheo-bronchial system since
the level of inflammatory activity is generally higher in the
airways compared to the vascular system. This expectation
a b
c d
Fig. 1 Ground sections (median, Richardson staining) of bare metal stents (a, b) and sirolimus-eluting stents (c, d) showing tissue proliferations
around the stent struts (black) in a similar degree; mucus is obstructing the lumen of the stent in c
Table 1 Experimental animals and histology results





Grams Proliferationa Granulocytesb Lymphocytesb Histocytes/FBRb
1 Bx Sonic 4.300 1 1 month + ++ ++ +
2 Bx Sonic 4.170 1 6 months + ++ ++ +
3 Bx Sonic 3.900 1 1 month + ++ ++ +
4 Bx Sonic 4.000 1 1 month ++ + ++ +
5 Bx Sonic 4.300 1 1 month + ++ ++ +
6 Bx Sonic 4.700 1 1 month + ++ ++ +
7 Cypher Select 4.760 1 1 month + ++ ++ +++
8 Cypher Select 4.310 1 6 months + + + ++
9 Cypher Select 4.110 1 1 month + ++ ++ +++
FBR foreign-body reaction
aGrading of the extent of granulation tissue with the lumen of the stents: 0 – no proliferation; + − lumen obstruction 1–25 %; ++ − lumen obstruction 26–50 %;
+++ − lumen obstruction >50 %
bGrading of inflammatory reactions describing the presence of different cell types around the stent struts: 0 – no inflammatory cells; + − light, noncircumferential
infiltrate; ++ − localized, moderate to dense cellular aggregate; +++ − circumferential, dense cell infiltration
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was further supported by the observation of reduced
granulation tissue formation during oral immunosuppres-
sant therapy in 30 adult patients with bare metal airway
stents [19].
In our study, however, we could not detect a positive
effect of sirolimus coating with regard to granulation tis-
sue formation. All three specimens containing sirolimus-
eluting stents showed significantly more foreign-body re-
action with multiple macrophages and foreign-body giant
cells around the stent struts. There is a well-described
relation of foreign-body reaction and formation of granu-
lation tissue [17, 20]. As a consequence, we speculate that
the extent of granulation tissue formation may even be
more pronounced in sirolimus-coated stents implanted
into the tracheo-bronchial system with an implantation
time of >12 months.
As in our study, increased inflammatory reactions
to drug-eluting stents (compared to bare metal stents)
with mainly macrophages but also with lymphocytes were
observed in a human coronary atherectomy specimen
[21, 22]. Degradable polymers of drug-eluting stents
were identified as the main trigger for these reactions
[23, 24].
To the best of our knowledge, no implantation of a
drug-eluting tracheo-bronchial stent has been reported
in humans. Only a few experimental studies examining
tracheo-bronchial stents with anti-proliferative coating
have been published as of yet. Chao et al. implanted
cisplatin-eluting biodegradable stents using the same
animal model as in our study. Re-epithelialization and
significant inflammatory infiltrates were observed after a
follow-up of up to 5 weeks [25]. The extent of granula-
tion tissue formation was not described, and the quality
of inflammatory reactions was not further specified. Zhu
et al. developed another bioabsorbable tracheal stent with
mitomycin C (MMC) drug elution [26]. After a maximum
implantation time of 12 weeks in rabbits, the group of
animals with drug-eluting stents showed less tracheal ob-
struction and mucus trapping compared to the bare metal
stent group. The latter is the only study to date that dir-
ectly compares drug-eluting and bare metal stents as it




Fig. 2 Stent strut (black structure, a) surrounded by mostly spindle-shaped cells embedded in fiber-rich connective tissue (bare metal stent;
Richardson blue staining); immunohistochemical staining (brown coloring) with antibodies against smooth muscle myosin (b; bare metal stent),
vimentin (c; sirolimus-eluting stent), and smooth muscle actin (d; bare metal stent) identifying the spindle-shaped cells as fibromuscular cells;
newly formed epithelium with polygonal cells lining the tracheo-bronchial lumen (e; bare metal stent; Richardson blue staining); cartilage
structure within the newly formed tissue (f, arrows; sirolimus-eluting stent; Richardson blue staining)
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more favorable results of the study of Zhu et al. might be
due to the differing mechanism of the anti-proliferative
coating.
Limitations
Significance of our results is limited due to the small
sample size which was related to the high rate of expec-
torated stents within the first months after stent place-
ment at the beginning of the experiments. Obviously, an
undersized balloon diameter chosen for implantation of
the stents in non-stenotic airways was the cause for this
issue. Expectorations occurred less frequent after modifi-
cation of the implantation procedure by employing a lar-
ger balloon size in relation to the airway diameter at the
site of implantation. Furthermore, results were obtained in
a rabbit animal model. No systematic data exist on trans-
ferability of results to human tissue reactions.
Conclusions
Our study demonstrates a similar extent of granulation
tissue formation in sirolimus-eluting tracheo-bronchial
stents in a small experimental series when compared to
bare metal stents. Foreign-body reaction was more pro-
nounced in the drug-eluting stent group after an observa-
tion period of 12 months which was by far longer than
reported in experimental studies in this field before.
Future perspective
Future studies may focus on new ways to effectively
reduce the formation of granulation tissue. This may be
achieved by a combination of the principles of drug elu-
tion and bioabsorption of the stents in order to avoid
chronic inflammation and subsequent granulation tissue
formation [26, 27]. Another promising approach may be
the implantation of bioresorbable airway splints indi-
vidually created in a three-dimensional printer which are
surgically implanted by external fixation at the region of
tracheomalacia as reported by Zopf et al. [28].
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